Kao M C, Law S L, Chuang T C, Lin Y S
Department of Biochemistry, National Defense Medical Center, P.O. Box 90048-501, Taipei, 100, Taiwan, R.O.C.
Oncol Rep. 1998 May-Jun;5(3):625-9. doi: 10.3892/or.5.3.625.
A new cationic liposome formulation of sphingosine (SP) and dioleoylphosphatidylethanolamine (DOPE) was developed as an efficient transfection reagent. This SP/DOPE liposome showed efficient transfection in a wide variety of mammalian cancer cells. No significant cytotoxicity of the SP/DOPE liposome to cells was observed. The tranfection activity was greater than that of a well-reported liposome which was made from a cholesterol derivative 3beta-[N-(N',N'-dimethylaminoethane)-carbamoyl] cholesterol (DC-Chol) and the neutral lipid DOPE. In addition, the SP/DOPE liposome was found to be less toxic to cells than the DC-Chol/DOPE liposome. Stable transfections mediated by SP/ DOPE liposome were also demonstrated. These results suggest that the SP/DOPE liposome may provide a good gene delivery system to be used in the human cancer gene therapy.
一种由鞘氨醇(SP)和二油酰磷脂酰乙醇胺(DOPE)组成的新型阳离子脂质体制剂被开发为一种高效的转染试剂。这种SP/DOPE脂质体在多种哺乳动物癌细胞中显示出高效转染能力。未观察到SP/DOPE脂质体对细胞有明显的细胞毒性。其转染活性高于一种由胆固醇衍生物3β-[N-(N',N'-二甲基氨基乙烷)-氨基甲酰]胆固醇(DC-Chol)和中性脂质DOPE制成的、报道广泛的脂质体。此外,发现SP/DOPE脂质体对细胞的毒性比DC-Chol/DOPE脂质体小。还证明了由SP/DOPE脂质体介导的稳定转染。这些结果表明,SP/DOPE脂质体可能为人类癌症基因治疗提供一种良好的基因递送系统。